Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
Build your Evidence Workspace
Save evidence about the topics you care about.
152
Studies
100
Evidence Pairs
Extensive Research
Evidence Base: 71/100
Evidence Intelligence™
Evidence Summary
A structured summary of where the evidence is strongest, mixed, or still emerging.
Executive Summary
Weight Loss evidence appears to center on Tirzepatide.
Among 152 indexed studies and 65 interventions, the strongest signals are summarized from the available evidence. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.
Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.
Caution
This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.
Key Finding
Evidence is consistently positive across multiple studies.
Interventions with strongest consistent evidence
Strongest consistent evidence
Why it matters
Consistent positive findings are easier to interpret than isolated or mixed results.
Interpretation
Tirzepatide appears to have a consistent beneficial signal in the indexed evidence.
Time-Restricted Eating (TRE), Lifestyle intervention for prediabetes, and Semaglutide are among the most studied approaches for Weight Loss.
Semaglutide, Empagliflozin, and Lifestyle intervention for prediabetes are among the best-supported options in the available evidence across 152 studies.
The evidence includes both beneficial and harmful or worsening results.
Why this answer: This answer is based on 14 supporting studies with consistent results and a positive effect signal.
Limitations
Population details are unavailable.
Time-Restricted Eating (TRE) vs Lifestyle intervention for prediabetes for weight loss?
compare
Strong Evidence
Time-Restricted Eating (TRE) and Lifestyle intervention for prediabetes have available evidence for Weight Loss, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are consistent across studies.
Why this answer: This answer is based on 38 supporting studies with consistent results and a positive effect signal.
Limitations
Population details are unavailable.
Evidence summary for AI and search
Among 152 indexed studies and 65 interventions, the strongest signals are summarized from the available evidence. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.
Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.
Evidence Relationships
Explore the intervention-outcome relationships with the strongest supporting evidence for Weight Loss.
20 strong relationships, ranked by available evidence